Completed PHASE3 INTERVENTIONAL 2-arm NCT03834129

Dexmedetomidine Intra Venous Arthroplasty (DIVA)

Interest of Intravenous Dexmedetomidine (Dexdor®) in the Knee Replacement Surgery Performed Under Locoregional Anesthesia: a Randomized, Double Blind, Controlled Clinical Trial

Sponsor: CMC Ambroise Paré

Conditions Primary Total Knee Arthroplasty

Interventions Dexmedetomidine sodium chloride 0.9%

Updated 6 times since 2019 Last updated: Feb 5, 2020 Started: May 13, 2019 Primary completion: Jan 11, 2020 Completion: Jan 11, 2020

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE3 trial investigates Primary Total Knee Arthroplasty and is currently completed. CMC Ambroise Paré leads this study, which shows 6 recorded versions since 2019 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE3
Jul 2024 — Sep 2024 [monthly]

Completed PHASE3
Jan 2021 — Jul 2024 [monthly]

Completed PHASE3
Mar 2020 — Jan 2021 [monthly]

Completed PHASE3

Status: Recruiting → Completed
Jun 2019 — Mar 2020 [monthly]

Recruiting PHASE3

Status: Not Yet Recruiting → Recruiting

▶ Show 1 earlier version

Mar 2019 — Jun 2019 [monthly]

Not Yet Recruiting PHASE3

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

CMC Ambroise Paré

Data source: CMC Ambroise Paré

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Toulouse, France